Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and org 2766

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with org 2766 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Darlington, C; Gilchrist, D; Smith, P1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and org 2766

ArticleYear
Org 2766 prevents disruption of vestibular compensation by an NMDA receptor antagonist.
    European journal of pharmacology, 1994, Jan-24, Volume: 252, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Anticonvulsants; Guinea Pigs; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Vestibular Function Tests; Vestibule, Labyrinth

1994